Javier Del Ser, the Chief Executive Officer (CEO) of AIM-listed construction materials producer Steppe Cement, topped up his stake in the firm on Tuesday with the purchase of 650,000 ordinary shares at a price of 25p per share.

Following the £162,500 transaction, Del Ser holds 12,867,660 ordinary shares in the company, equal to 7.19% of the total issued share capital.

Steppe is a leading cement producer in Kazakhstan. Its cement production facilities consist of four wet kilns and one energy efficient dry kiln.

Del Ser is the Chairman of Steppe's operating subsidiaries, Central Asia Cement and Karcement. He has other business interests in Kazakhstan, including being a director and large shareholder in the Chagala Group.

The company said last week that third-quarter revenue was 28% higher than the year before at KZT 7,233m. Sales volumes of 518,433 tonnes were up 16% during the three months to September 30th.


Top Director Buys

Steppe Cement Ltd (STCM)
Director name: Mr Javier del Ser Perez
Amount purchased: 650,000 @ 25.00p
Value: £162,500

Smiths Group (SMIN)
Director name: Mr Peter Turner
Amount purchased: 8,996 @ 1,048.15p
Value: £94,292

Deltex Medical Group (DEMG)
Director name: Mr Nigel J Keen
Amount purchased: 138,888 @ 24.00p
Value: £33,333

Deltex Medical Group (DEMG)
Director name: Mr Edwin Snape
Amount purchased: 100,000 @ 24.00p
Value: £24,000

Deltex Medical Group (DEMG)
Director name: Mr Charles Julian Cazalet
Amount purchased: 90,000 @ 24.00p
Value: £21,600

Deltex Medical Group (DEMG)
Director name: Sir Duncan K Nichol
Amount purchased: 75,000 @ 24.00p
Value: £18,000

Related share prices
Smiths Group (SMIN) share price
Deltex Medical Group (DEMG) share price
Steppe Cement Ltd (STCM) share price